Globally, the meningococcal vaccines market was worth USD 1.5 billion as of 2012. It is projected to touch USD 3.7 billion by 2019. With a compounded annual growth rate (CAGR) 14.9% between 2013 and 2019, this market is poised to witness strong growth. This article provides an overview of the disease before going on to discuss the reasons for a higher demand for meningococcal vaccines.

1. Global Meningococcal Vaccines Market to
Reach US$4.4 bn by 2022, Concerns over
Increasing Incidence of Meningococcal
Infections to Fuel Demand
Transparency Market Research (TMR) has recently published a
report on the global meningococcal vaccines market, according
to which the market is estimated to expand at a healthy CAGR
of 12.40% during the period between 2014 and 2022.The
research report, titled “Meningococcal Vaccines Market - Global
Industry Analysis, Size, Share, Growth, Trends and Forecast
2014 - 2022,” projects this market to rise from an overall value
of US$1.5 bn in 2013 to US$4.4 bn by the end of the forecast
period.
Meningococcal disease caused by the bacterium Neisseria
meningitidis is a life threatening condition which severely
infects the meninges or the thin lining surrounding the brain and
the spinal cord. Five out of many serogroups of the bacterium
are responsible for the invasive meningococcal disease.
These serogroups are predominantly present only in humans in
the dormant state and may eventually cause the diseased
condition due to environmental or immunogenic factors. The
disease is known to be contagious and its consequences can be
fatal within 24 hours from the onset of symptoms. Prevalence of

2. the serogroups responsible for the disease varies with age, time
and geographical locations.
Browse Full Research Report on Meningococcal Vaccines
Market:
http://www.transparencymarketresearch.com/meningococcal-
vaccines-market.html
Meningococcal infections such as meningococcemia,
meningococcal pneumonia, and Meningitis are caused by
Neisseria meningitidis and carry a high risk of mortality if left
untreated. However, these infections can be prevented by
meningococcal vaccines. Various versions of these vaccines are
85% to 100% efficient against different types of meningococcus,
resulting in a swift recovery from sepsis and meningitis.
The research report has evaluated the worldwide meningococcal
vaccines market on the basis of the type of meningococcal
vaccine and the geographical distribution of this market. Based
on the type, the market has been segmented into conjugate
vaccines, men b vaccines, combination vaccines, and
polysaccharide vaccines.
In terms of revenue, the conjugate vaccines segment is expected
to dominate the global market for meningococcal vaccines in the
coming years. During the forecast period, the segment is likely

3. to rise at a CAGR of 11.10% and reach a value of US$3.1 bn by
the end of it.
On the regional basis, the worldwide meningococcal vaccines
market has been segmented into Asia Pacific, Europe, North
America, and the Rest of the World. In 2013, North America
held the leading position in this market. However, Asia Pacific is
likely to emerge as the fastest growing regional market for
meningococcal vaccines over the forecast period.
The continual rise in the region’s population base and the
increasing focus on preventive measures against meningococcal
infections are the major factors driving the growth of this
regional market, states the research report.
The report also studies the competitive landscape of the global
market for meningococcal vaccines by profiling the key
companies operating in this market. Serum Institute of India
Ltd., Sanofi SA, Pfizer Inc., Nuron Biotech Inc., JN-
International Medical Corp., GlaxoSmithKline Plc, Biomed Pvt.
Ltd., Novartis International AG, and Baxter International Inc.
have been identified as the leading meningococcal vaccine
producers in the global arena. Among these, Sanofi, GSK Plc,

4. and Novartis International dominate the worldwide market with
a collective share of approximately 90%, notes the market study.
Browse Full Press Release on Meningococcal Vaccines
Market:
About Us
Transparency Market Research (TMR) is a global market
intelligence company providing business information reports
and services. The company’s exclusive blend of quantitative
forecasting and trend analysis provides forward-looking insight
for thousands of decision makers. TMR’s experienced team of
analysts, researchers, and consultants use proprietary data
sources and various tools and techniques to gather and analyze
information.
TMR’s data repository is continuously updated and revised by a
team of research experts so that it always reflects the latest
trends and information. With extensive research and analysis
capabilities, Transparency Market Research employs rigorous
primary and secondary research techniques to develop
distinctive data sets and research material for business reports.
Press Release

5. Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com